Back to
PICTON MAHONEY ASSET MANAGEMENT
EPRX1 quarters
Position history for
PICTON MAHONEY ASSET MANAGEMENT's holdings in EUPRAXIA PHARMACEUTICALS INC
Yes. Picton Mahoney Asset Management holds 360,878 shares of EPRX (Eupraxia Pharmaceuticals), worth $2.4M, as of its Q2 2026 13F filing. It opened the position in Q2 2026.
Current Value
$2.4M
Current Shares
360,878
Total Value Change
$0
Total Shares Change
0
Quarter-by-Quarter History
Other major holders of EPRX: BALYASNY ASSET MANAGEMENT L.P., SCOTIA CAPITAL INC.